VR

Xeris Biopharma’s Impressive Leap: Surpassing Expectations and Shaping the Future

Xeris Biopharma’s Impressive Leap: Surpassing Expectations and Shaping the Future

7 March 2025
Xeris Biopharma reported over $203 million in revenue for 2024, a 24% increase from the previous year. The product Recole experienced a 118% revenue surge due to strategic expansion and strengthening of prescriber relationships. Caveyas faced a 13% revenue decline, challenged by pricing pressures and reimbursement issues, but shows signs of stabilization. XP 8,121 completed phase 2 study; phase 3

Xbox

Playstation

The Surprising Catalyst Behind AMD’s Gaming Revolution

The Surprising Catalyst Behind AMD’s Gaming Revolution

2 March 2025
AMD leads a transformative shift in the gaming industry, driven by significant stock movement in after-hours trading. The integration of artificial intelligence into gaming processors by AMD promises to create immersive, intelligent gaming experiences. Strategic partnerships with major players like Microsoft and Sony position AMD’s technology at the core of next-gen gaming consoles. Investors are alerted by stock fluctuations, indicating

Latest

1 2 3 1,359